Reviva to present at the ubs virtual cns day

Cupertino, calif., march 11, 2024 (globe newswire) -- reviva pharmaceuticals holdings, inc. (nasdaq: rvph) (“reviva” or the “company”), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system (cns), inflammatory and cardiometabolic diseases, today announced that laxminarayan bhat, ph.d., founder, president, and ceo of reviva will participate in a fireside chat at the ubs virtual cns day, taking place virtually march 18, 2024.
RVPH Ratings Summary
RVPH Quant Ranking